Subscribe

Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

Newsdesk

402 Posts

FDA Shift In Drug Approvals Halts Trial Of Second Skin Cancer Drug post image
regulatory fda clinical-trials

FDA Shift In Drug Approvals Halts Trial Of Second Skin Cancer Drug

by Newsdesk
Novel Gene Therapy for ALS cleared for global trials in China and the U.S. post image
regulatory fda clinical-trials

Novel Gene Therapy for ALS cleared for global trials in China and the U.S.

by Newsdesk
COVID-19 "Vaccine Alternative" Based On Monoclonal Antibodies May Be On A Fast-Track To FDA Approval post image
regulatory fda clinical-trials

COVID-19 "Vaccine Alternative" Based On Monoclonal Antibodies May Be On A Fast-Track To FDA Approval

by Newsdesk
U-turn on Mounjaro price hike: drug giant scales back planned rise after backlash - new costs revealed in full post image
pharma-industry business earnings

U-turn on Mounjaro price hike: drug giant scales back planned rise after backlash - new costs revealed in full

by Newsdesk
Invivyd Aligns with U.S. FDA on Rapid Pathway to Full Approval (BLA) of Vaccine Alternative Monoclonal Antibody VYD2311 to Protect American Adults and Adolescents from COVID-19 post image
regulatory fda clinical-trials

Invivyd Aligns with U.S. FDA on Rapid Pathway to Full Approval (BLA) of Vaccine Alternative Monoclonal Antibody VYD2311 to Protect American Adults and Adolescents from COVID-19

by Newsdesk
Unveiling 'Bugonia': A Comedic Thriller of Our Times post image
pharma-industry business earnings

Unveiling 'Bugonia': A Comedic Thriller of Our Times

by Newsdesk
Teva Pharmaceutical Wins FDA Nod For First-Ever Generic Weight-Loss Drug post image
pharma-industry business earnings

Teva Pharmaceutical Wins FDA Nod For First-Ever Generic Weight-Loss Drug

by Newsdesk
SciSparc: AutoMax’s Shareholders Approve Merger with SciSparc post image
pharma-industry business earnings

SciSparc: AutoMax’s Shareholders Approve Merger with SciSparc

by Newsdesk
Aptamer Group introduces novel biomarker discovery service post image
pharma-industry business earnings

Aptamer Group introduces novel biomarker discovery service

by Newsdesk
Zero trust critical for data protection and drug authenticity in pharma post image
pharma-industry business earnings

Zero trust critical for data protection and drug authenticity in pharma

by Newsdesk
Transformative Growth in Indian Cardiac and Diabetic Pharma Franchises post image
pharma-industry business earnings

Transformative Growth in Indian Cardiac and Diabetic Pharma Franchises

by Newsdesk
Creative Medical Technology Holdings Secures FDA Fast Track Designation for CELZ-201-DDT - Advancing Breakthrough Therapy for Chronic Lower Back Pain post image
breakthrough research innovation

Creative Medical Technology Holdings Secures FDA Fast Track Designation for CELZ-201-DDT - Advancing Breakthrough Therapy for Chronic Lower Back Pain

by Newsdesk